Cogitum solution 25mg / ml, No. 30
Expiration Date: 05/2027
Russian Pharmacy name:
Когитум раствор 25мг/мл, №30
Complex therapy of asthenic syndrome.
Inside.
The dose is prescribed individually by the doctor.
Adults: The average dose is 3 amp. per day: 2 - in the morning and 1 - at night. The maximum dose is unknown.
Children: from 7 to 10 years old - 1 amp is recommended. in the morning; from 10 to 18 years old - 2 amp. in the morning.
For reception, you need to open the ampoule on one side, then, substituting a glass or cup under the opened end, break off the opposite end of the ampoule. After that, the liquid will freely pour into the substituted container. The taste of the drug allows you to use it without prior dilution. If diluted with water, the banana flavor may be lost. Morning intake of the drug is most preferable.
The average duration of treatment in children and adults is 3 weeks.
If for some reason one or more doses of the drug were missed, then the treatment can be continued without the need for a secondary dose adjustment. Treatment can also be stopped abruptly without any serious consequences for the patient.
| Oral solution | 10 ml |
| active substance: | |
| potassium acetylaminosuccinate | 250 mg |
| excipients: fructose - 1000 mg; methyl parahydroxybenzoate - 15 mg; banana flavor - 7 mg; purified water - up to 10 ml |
hypersensitivity reactions to acetylaminosuccinic acid or any other component of the drug;
pregnancy (insufficient clinical data);
children under 7 years of age (clinical data are not available).
Pharmacological action
The drug has a general tonic action. The active principle of the drug is acetylamino succinic acid, a biologically active compound contained in the central nervous system. The drug helps to normalize the processes of nervous regulation, has a stimulating effect.
Pharmacokinetics
Data on the pharmacokinetics of the drug Cogitum are not provided.
Side effect
Allergic reactions are possible.
Special instructions
The drug can be used in elderly patients.
Influence on the ability to drive vehicles and control mechanisms. It is unlikely that the drug can affect the ability to drive vehicles, mechanisms or engage in other potentially hazardous activities.
Overdose
Currently, no cases of overdose of the drug Cogitum have been reported. No toxic effects are expected.
Drug interaction
Interaction of the drug Kogitum with other drugs has not been observed.
Terms and conditions of storage
The drug should be stored out of the reach of children, protected from light, at a temperature not exceeding 25 ? C.
Shelf life is 3 years.
Conditions for dispensing from pharmacies
The drug is approved for use as a non-prescription drug.